~20 spots leftby Dec 2025

Tech-PN for Pelvic Inflammatory Disease

Palo Alto (17 mi)
Overseen byMaria Trent, MD, MPH
Age: < 65
Sex: Female
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: N/A
Waitlist Available
Sponsor: Johns Hopkins University
No Placebo Group

Trial Summary

What is the purpose of this trial?The investigators are enrolling 150 young women 13-25 years old diagnosed with pelvic inflammatory disease (PID) in Baltimore to receive community health nurse (CHN) clinical support visits and short messaging system communication support for 30 days. The investigators' intervention group(TECH-PN) will receive additional testing and treatment in the field. The investigators hypothesize that repackaging the recommended Centers for Disease Control and Prevention (CDC) follow-up visit using a technology-enhanced community health nursing intervention (TECH-N) with integration of an evidence-based sexually transmitted infection (STI) prevention curriculum will reduce rates of short-term repeat infection by improving adherence to PID treatment and reducing unprotected intercourse and be more cost-effective compared with outpatient standard of care (and hospitalization).

Eligibility Criteria

This trial is for young women aged 13-25 in the Baltimore area who have been diagnosed with mild to moderate pelvic inflammatory disease (PID) and are not pregnant. Participants must be willing to sign informed consent, agree to randomization, and be able to communicate and complete study procedures.

Exclusion Criteria

I cannot communicate or follow study procedures.

Treatment Details

The trial is testing a new approach called TECH-PN which includes community health nurse visits and text message support for 30 days, plus additional field testing and treatment. It aims to improve adherence to PID treatment, reduce unprotected sex, prevent repeat STI infections, and evaluate cost-effectiveness against standard care.
2Treatment groups
Experimental Treatment
Active Control
Group I: TECH-PNExperimental Treatment1 Intervention
Participants receive community health nurse visits, text-messaging support, additional testing and field based visits with a nurse practitioner.
Group II: TECH-NActive Control1 Intervention
Participants receive enhanced standard of care with community health nurse visits and text-messaging support.

Find a clinic near you

Research locations nearbySelect from list below to view details:
Johns Hopkins School of MedicineBaltimore, MD
Loading ...

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
National Institute of Nursing Research (NINR)Collaborator

References